Saturday, January 31, 2026

Hyundai and Kia Hit 30K EV Sales in U.S.—IONIQ 5 Leads the Charge

Hyundai Motor Group sold over 30,000 electric vehicles in the U.S. in Q1 2025, ranking third in the market with the IONIQ 5 leading sales.

NVIDIA Surges Again! Stock Hits $123.51 as AI Hype Grows!

NVIDIA surged over 2% following a positive report from Bain & Company, reclaiming a market capitalization of $3 trillion.

A Korean Mobility Startup Heads to Silicon Valley: Why Chabot Mobility Is Testing the U.S. Market Now

Chabot Mobility is now a resident at K-Startup Center in Silicon Valley, enhancing its global expansion and investment opportunities.

Tag: obesity

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Dark Skin Patches in Teens? It Could Be a Warning Sign, Doctors Say

Dark patches on skin folds in adolescents may indicate Acanthosis Nigricans, linked to obesity and insulin resistance. Consult a specialist.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

Underweight People Face Higher Suicide Risk, Study Shows

A study reveals underweight individuals face a higher suicide risk, while overweight individuals show a lower risk, emphasizing BMI's impact.

Study Reveals Semaglutide Reduces Cravings and Helps Control Weight and Blood Sugar

A study shows oral semaglutide aids weight loss and reduces cravings for sugary foods in type 2 diabetes patients.

Could You Have Diabetes? Here’s What You Should Know About the Rising Numbers

In 2022, 14.8% of adults over 30 had diabetes; effective management remains a challenge despite rising awareness and lifestyle changes.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.